November 22 – Ten executives of Qianjiang Yongan Pharmaceutical (002365.SZ) cashed in 202 million yuan from the disposal of 12.86 million shares over the course of 11 transactions between November 2 and 17, reports ccstock.com. According to the company board secretary, the equity sales were due to “personal reasons.” The 10 executives sold the equity at an average per-share price of 15.72 yuan.

Yongan Pharmaceutical generated net profits of 55.12 million yuan in the first nine months, up 53.29 percent year-on-year. It earned 20.84 million in third quarter alone, an increase of 97.45 percent.

For the first three quarters, the firm yielded earnings per share (EPS) of 0.29 yuan, rising 45 percent from the same period in 2010. Yongan Pharmaceutical had 450 million yuan worth of idle funds and a debt ratio of 8.51 percent as of September 30.